Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RECLAIM: an Adaptive Platform Trial for the Evaluation of Treatments for Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

NCT07280572 is registered in ClinicalTrials.gov with Janneke van de Wijgert as lead sponsor.

NCT NCT07280572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07280572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RECLAIM: an Adaptive Platform Trial for the Evaluation of Treatments for Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Lead sponsor
Janneke van de Wijgert
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
February 17, 2025
Completion date
December 1, 2027
Enrollment
1,250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post covid condition